TMC/AD/17/2015

Required Research Fellow (Medical)on on “A Phase III Randomized, Double Blind, Parallel Group Multicentre Study To Compare The Efficacy, Safety, Pharmacokinetics And Immunogenicity Between Sb3 (Proposed Trastuzumab Biosimilar) And Herceptin In Women With Newly Diagnosed HER2 Positive Early Or Locally Advanced Breast Cancer In Neoadjuvant Setting” Project (A/c No. 3269)  Initially for a period of six months.

Interested candidates may contact Project Office, Service Block Building, 4^th Floor, Dr. Ernest Borges Marg, Parel, Mumbai - 400012 along with Bio-data, recent passport size photograph, Xerox copy of PANCARD, original certificates and one set of attested copies of all certificates.

For further details contact No. 24177000   Extn. 4666.

                                                                                                                                                                                                     [P.K.SUKUMARAN]

                                                                                                                                                                                                       H.R.D. OFFICER